Studies Show SI-BONE's iFuse Implant System Saves Time, Money (ODTMag)
SI-BONE Inc. has announced the publication of two economic studies showing the cost benefits of MIS SI joint fusion for patients suffering from chronic SI joint dysfunction due to degenerative sacroiliitis or SI joint disruption.
In the first article, titled, “Cost Effectiveness of Minimally Invasive Sacroiliac Joint Fusion,” researchers combined data collected from INSITE, a prospective randomized controlled trial, and SIFI, a prospective single-arm trial, with 2015 Medicare national average reimbursement allowable data to calculate incremental costs and health benefits of SIJ fusion vs. non-surgical management (NSM) in patients with chronic SIJ dysfunction. The purpose of the study was to calculate an incremental cost effectiveness ratio (ICER), which measures the relative cost of gains in quality of life associated with SIJ fusion. Using a Markov model that describes health states of patients with SIJ dysfunction who undergo either surgical or non-surgical treatment, the study showed a five-year gain in quality of life of 0.74 quality-adjusted life years (QALYs) at an incremental cost of $9,833, which corresp...
